B. Riley Securities Downgrades Anterix to Neutral, Raises Price Target to $69
Benzinga Newsdesk 5 months ago
NewsDowngradesPrice TargetAnalyst Ratings
B. Riley Securities analyst Mike Crawford downgrades Anterix (NASDAQ:ATEX) from Buy to Neutral and raises the price target from $44 to $69.
B. Riley Securities analyst Mike Crawford downgrades Anterix (NASDAQ:ATEX) from Buy to Neutral and raises the price target from $44 to $69.